美国,Peregrine Pharmaceuticals,  
Peregrine Pharmaceuticals总部设在美国加州，是一家生物医药公司，主要以collateral targeting technologies为主的治疗癌症的独特技术的开发，商品化和权利许可。

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. We are pursuing multiple clinical programs in cancer with our lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers.